Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) saw strong trading volume on Tuesday . 1,541,046 shares were traded during mid-day trading, an increase of 112% from the previous session's volume of 726,477 shares.The stock last traded at $2.84 and had previously closed at $2.76.
Analyst Upgrades and Downgrades
Separately, Cormark upgraded shares of Curaleaf from a "hold" rating to a "moderate buy" rating in a report on Friday, August 8th.
Read Our Latest Analysis on Curaleaf
Curaleaf Stock Down 9.5%
The stock has a market capitalization of $1.78 billion, a P/E ratio of -8.31 and a beta of 0.69. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.47 and a quick ratio of 0.70. The stock's fifty day moving average is $1.27 and its two-hundred day moving average is $1.11.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. As a group, research analysts predict that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current fiscal year.
About Curaleaf
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Recommended Stories
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.